HITGEN

Serial Number 79272412
Registration 6150102
700

Registration Progress

Application Filed
Apr 11, 2019
Under Examination
Approved for Publication
Jun 30, 2020
Published for Opposition
Jun 30, 2020
Registered
Sep 15, 2020

Attorney Assistance

Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200915)
Due: Sep 15, 2026 253 days

Trademark Image

HITGEN

Basic Information

Serial Number
79272412
Registration Number
6150102
Filing Date
April 11, 2019
Registration Date
September 15, 2020
Published for Opposition
June 30, 2020
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 15, 2020
Registration
Registered
Classes
001 005 035 042

Rights Holder

HitGen Inc.

99
Address
Floor 3, Building 1,
No. 88, Keyuan South Road, High-tech Zone, Chengdu, Sichuan
CN

Ownership History

HITGEN LTD.

Original Applicant
99
CN

HITGEN LTD.

Owner at Publication
99
CN

HitGen Inc.

Original Registrant
99
CN

Legal Representation

Attorney
Eric J Maiers

USPTO Deadlines

Next Deadline
253 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200915)
Due Date
September 15, 2026
Grace Period Ends
March 15, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Sep 15, 2025 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Dec 8, 2023 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Nov 10, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jan 23, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Dec 31, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Dec 30, 2020 FIMP P FINAL DISPOSITION PROCESSED Loading...
Dec 15, 2020 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Sep 15, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 30, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 30, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 10, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 27, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 19, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 18, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 18, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 24, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Jan 4, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jan 4, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Dec 7, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 5, 2019 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Dec 4, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 3, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 3, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 27, 2019 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Nov 21, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 001
Chemical reagents other than for medical or veterinary purposes; biological reagents other than for medical or veterinary purposes; biochemical catalysts; DNA encoded chemical compound for use in biochemical research; DNA encoded chemical preparations for use in biochemical research; intermediate of DNA encoded chemical compound for use in biochemical research; headpiece of DNA encoded chemical compound for use in biochemical research
Class 005
Medicines for human purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease or ophthalmic diseases; chemical preparations for medical purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease or ophthalmic diseases; chemical preparations for pharmaceutical purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease or ophthalmic diseases; chemico-pharmaceutical preparations for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease or ophthalmic diseases
Class 035
Shop window dressing; outdoor advertising; bill-posting; distribution of samples; publicity services
Class 042
Technical project studies, namely, technical research in the field of pharmaceutical studies; chemical research services; chemical research; biological research; research and development services relating to DNA encoded library synthesis; research and development services relating to DNA encoded library selection; research and development services relating to DNA encoded library data analysis

Additional Information

Design Mark
The mark consists of the stylized wording "HITGEN" with the letter I in red and the other letters in blue. The color "white" appears as background only and is not claimed as a feature of the mark.
Color Claim
The color(s) red and blue is/are claimed as a feature of the mark.

Classification

International Classes
001 005 035 042